(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):
-Earnings: -$314 million in Q3 vs. -$273 million in the same period last year. -EPS: -$0.29 in Q3 vs. -$0.27 in the same period last year. -Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $637 million or $0.58 per share for the period. -Analysts projected $0.59 per share -Revenue: $4.26 billion in Q3 vs. $4.53 billion in the same period last year.
-Guidance: Full year EPS guidance: $2.30 - $2.50 Full year revenue guidance: $17.2 - $ 17.4 Bln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.